KOSPIChemicals268280

Miwon Specialty Chemical

₩122,000▲ 2.52%2026-11-18 close
Market Cap
₩610B
Turnover
₩100M
Volume
939 shares
Shares out.
5M
PER
9.0×
PBR
1.3×
EPS
₩14,497
Dividend Yield
2.44%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩3,200 per share · Prices as of the 2026-11-18 close

01

Report overview

Energy-curable resin leader; Q3 2026 profit drop is the key question

Miwon Specialty Chemical holds a domestic market share above 50% in energy-curable resins. Annual profit recovered from the 2023 trough, but Q3 2026 net profit attributable to controlling shareholders fell to KRW 96.09 million, so the cause of that drop is the key item to confirm.

  1. 1

    Operating profit for 2025 was KRW 65.5 billion, with the operating margin recovering to 12.3% from the 5.1% trough in 2023.

  2. 2

    Q2 2026 revenue of KRW 162.8 billion is the highest of the last five quarters on a reported basis, and operating profit for that quarter was KRW 37.1 billion.

  3. 3

    Q3 2026 operating profit fell 55.0% from the prior quarter to KRW 16.7 billion, and net profit attributable to controlling shareholders was only KRW 96.09 million, while revenue rose 21.4% year on year.

  4. 4

    The debt ratio at the end of 2025 was 22.5%, with total equity of KRW 448.5 billion and total liabilities of KRW 100.7 billion.

  5. 5

    Miwon Holdings and its related parties reported holding 73.58% of the shares as of March 23, 2026.

02

Business structure

Miwon Specialty Chemical was spun off from Miwon Holdings in 2017 and later listed on the KOSPI. The company produces monomers, oligomers and related polymers, core materials for energy curing, and supplies them worldwide. These materials are widely used in coatings, inks, adhesives and electronic materials.

As of Q2 2026 sales, energy-curable resins and other products accounted for 99% of revenue, with services at 1%, so the business is concentrated in a single material family. Domestic market share was 50% and overseas market share was 15% as of September 2025.

The company describes itself as having the longest history among domestic chemical manufacturers and operates production and sales subsidiaries in the United States and Germany, along with research facilities. Exports made up 82.7% of consolidated sales in December 2025, against 17.3% domestic.

The only consolidated subsidiary is Miwon Specialty Chemical USA, Inc., established in October 2018. R&D spending in 2025 was KRW 6.08 billion, or 1.14% of sales.

Competition overlaps with larger listed peers such as LG Chem, Hanwha Solutions, SKC and Kumho Petro Chemical, but those groups have broader portfolios, so scale and structure are not directly comparable with a company centered on one product family.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩133.3B₩18.2B13.6%
2025Q4₩126.1B₩10.1B8.0%
2026Q1₩141.3B₩19.3B13.6%
2026Q2₩162.8B₩37.1B22.8%
2026Q3₩161.9B₩16.7B10.3%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩611.6B₩80.9B₩64.8B13.2%17.1%25.6%
2023₩437.7B₩22.5B₩18.6B5.1%5.0%23.6%
2024₩509.3B₩58.8B₩54.6B11.5%13.4%26.0%
2025₩532.1B₩65.5B₩61.3B12.3%13.7%22.5%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-13

04

Earnings analysis

Annual revenue fell from KRW 611.6 billion in 2022 to KRW 437.7 billion in 2023, a 28.4% decline, then rose 16.4% to KRW 509.3 billion in 2024 and 4.5% to KRW 532.1 billion in 2025. Revenue increased for two consecutive years from 2024 through 2025, following the 2023 low.

The largest year of the 2022 to 2025 period was 2022, and the smallest was 2023. Operating profit went from KRW 80.9 billion in 2022 to KRW 22.5 billion in 2023, a 72.1% decline, then rose 160.9% to KRW 58.8 billion in 2024 and 11.4% to KRW 65.5 billion in 2025, increasing for two consecutive years from the 2023 low.

The operating margin was 13.2% in 2022, 5.1% in 2023, 11.5% in 2024 and 12.3% in 2025. In the 2023 downturn, the consolidated cost of sales ratio rose from 78.44% to 87.64%, adding cost pressure; it then eased to 79.77% in 2024 and 78.76% in 2025 as margins recovered.

Net profit attributable to controlling shareholders was KRW 64.8 billion in 2022, KRW 18.6 billion in 2023 (down 71.3%), KRW 54.6 billion in 2024 (up 193.3%) and KRW 61.3 billion in 2025 (up 12.3%). Net profit including non-controlling interests was reported at the same yearly values.

Operating cash flow was KRW 39.4 billion in 2022, KRW 109.2 billion in 2023, KRW 54 billion in 2024 and KRW 76.5 billion in 2025, so cash generation was strongest in 2023, the year of the profit trough.

On a quarterly basis, revenue was KRW 133.3 billion in Q3 2025, KRW 126.1 billion in Q4 2025 (down 5.4% from the prior quarter), KRW 141.3 billion in Q1 2026 (up 12.0%), KRW 162.8 billion in Q2 2026 (up 15.3%) and KRW 161.9 billion in Q3 2026 (down 0.6% from the prior quarter, up 21.4% year on year).

Operating profit was KRW 18.2 billion in Q3 2025, KRW 10.1 billion in Q4 2025 (down 44.5%), KRW 19.3 billion in Q1 2026 (up 90.9%), KRW 37.1 billion in Q2 2026 (up 92.5%) and KRW 16.7 billion in Q3 2026 (down 55.0% from the prior quarter, down 8.2% year on year).

Net profit attributable to controlling shareholders was KRW 17.8 billion in Q3 2025, KRW 15.2 billion in Q4 2025, KRW 21.5 billion in Q1 2026, KRW 33 billion in Q2 2026 and KRW 96.09 million in Q3 2026, and the four quarters from Q4 2025 to Q3 2026 total KRW 69.8 billion.

Q3 2026 operating profit was less than half of Q2 2026, and the gap between operating profit and controlling-shareholder net profit widened; the drivers, such as non-operating items and income tax, need to be confirmed from disclosure line items.

05

Industry analysis

Energy-curable resins, also called UV and EB curable resins, harden within a short time and serve as process materials across coatings, inks, adhesives and electronic materials. Domestic market share was 50% as of September 2025, so the company holds a large share of domestic demand.

Overseas market share is 15%, leaving room for expansion abroad. With exports at 82.7% of consolidated sales, overseas demand and exchange rates have a direct effect on revenue and margins.

Industry summaries from around 2025 cited rising raw material prices and supply chain issues as challenges across the sector. 2023 was the year when revenue fell 28.4% and the cost of sales ratio rose to 87.64%, making it the period of largest earnings swings.

In 2024 and 2025 the cost ratio returned to the 78% range and margins recovered. On competition, LG Chem, Hanwha Solutions, SKC and Kumho Petro Chemical are large chemical groups with broader portfolios, so their market position is hard to compare directly with a company focused on one product family.

The company emphasizes its long domestic history and its network of overseas subsidiaries as sources of customer reach. Revenue held in the KRW 160 billion range in Q2 and Q3 2026, which points to demand stability, while operating margins moved sharply between quarters.

06

Outlook

At the annual general meeting on March 19, 2026, shareholders approved a partial amendment to the articles of incorporation by special resolution.

The amendment added real estate leasing, holding-company business through ownership of subsidiary shares, joint product development and sales with subsidiaries, and administrative support services to the business purpose.

The same meeting approved a cash dividend, and the financial statements, both consolidated and standalone, received a clean audit opinion. Consolidated total assets for 2025 were reported at KRW 549.2 billion and total equity at KRW 448.5 billion.

R&D spending rose from KRW 4.85 billion in 2024, or 0.95% of sales, to KRW 6.08 billion in 2025, or 1.14% of sales. Overseas, the company describes using its production and sales subsidiaries and research facilities in the United States and Germany to widen customer reach.

Q4 2026 results have not yet been filed in a periodic report, so the most recent quarter on a reported basis remains Q3 2026. The next check is whether the gap between Q3 2026 operating profit and net profit attributable to controlling shareholders carries into full-year results.

Operating margin also needs watching, since it fell from roughly 22.8% in Q2 2026 to the low 10% range in Q3 2026. The added holding-company purpose also makes follow-up subsidiary disclosures and governance changes relevant to check.

07

Valuation

PER
9.0×
PBR
1.3×
ROE
15.2%
EPS
₩14,497
BPS
₩99,859
Dividend per share
₩3,200

When reading the price-to-earnings multiple, the earnings base in the denominator needs to be examined first. Annual net profit attributable to controlling shareholders was KRW 61.3 billion in 2025, up for two consecutive years from the 2023 low, but it fell sharply in Q3 2026.

The four quarters from Q4 2025 to Q3 2026 total KRW 69.8 billion, and quarterly swings are large enough that one or two quarters alone make the multiple hard to interpret.

The price-to-book ratio sits above 1x, meaning the share price trades at a premium to net asset value attributable to controlling shareholders of KRW 448.5 billion. A cash dividend was approved at the March 2026 annual general meeting, with a total payout reported at about KRW 15.4 billion.

Because Miwon Holdings and related parties hold a high share of the company, the free float is limited.

An operating margin of 12.3% and a debt ratio of 22.5% are factual indicators of profitability and financial burden, and reading them alongside the multiples shows how earnings volatility relates to the capital structure.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-13

08

Bull factors

Recovery in operating margin

The operating margin rose from 5.1% in 2023 to 11.5% in 2024 and 12.3% in 2025. Operating profit reached KRW 37.1 billion in Q2 2026, the highest quarterly figure on a reported basis among the last five quarters. Revenue holding in the KRW 160 billion range in Q2 and Q3 2026 also supports that recovery.

Domestic market position and overseas base

The domestic energy-curable resin market share was 50% as of September 2025. The company describes itself as having the longest history among domestic chemical makers and operates production and sales subsidiaries and research facilities in the United States and Germany. The overseas share of 15% indicates room for further expansion abroad.

Financial stability and cash generation

The debt ratio at the end of 2025 was 22.5%, down from 25.6% in 2022. Total liabilities were KRW 100.7 billion and total equity was KRW 448.5 billion. Operating cash flow was KRW 76.5 billion in 2025, and it reached KRW 109.2 billion in 2023, the year of the profit trough.

09

Bear factors

Sharp profit drop in Q3 2026

Q3 2026 operating profit fell to KRW 16.7 billion, down 55.0% from the prior quarter and 8.2% year on year. Net profit attributable to controlling shareholders was KRW 96.09 million, down 99.7% from the prior quarter and 99.5% year on year. Revenue reached KRW 161.9 billion, up 21.4% year on year, but profit did not follow revenue in that quarter.

Earnings volatility and cost pressure

In 2023 revenue fell 28.4% and operating profit fell 72.1%, while the cost of sales ratio rose to 87.64%. Operating profit was KRW 10.1 billion in Q4 2025, down 44.5% from the prior quarter. The quarterly profit swings are large, which widens the range of outcomes for future earnings.

Export dependence and single product structure

Exports accounted for 82.7% of consolidated sales in December 2025, so overseas demand and exchange rates feed directly into results. As of Q2 2026 sales, energy-curable resins and other products made up 99% of revenue, concentrating the business in one material family. A slowdown in demand for that family would weigh heavily on total sales.

10

Risk factors

Concentration risk

Energy-curable resins and related products account for 99% of revenue. If demand across coatings, inks, adhesives and electronic materials moves together, results could swing sharply at once. Whether the portfolio broadens will show up in future disclosures of business mix.

Export and currency exposure

With exports at 82.7% of sales, currency movements affect translated revenue and profitability. Overseas bases in the United States and Germany also expose the company to local demand and pricing competition. If raw material prices rise at the same time, margins could come under pressure.

Governance and float

Miwon Holdings and related parties held 73.58% as of March 23, 2026. With a limited free float, the range of share supply and demand may be narrow.

The March 2026 amendment added holding-company and real estate leasing activities to the business purpose, so any shift in strategy needs to be confirmed through follow-up filings.

11

What to watch next

  1. December 31, 2026

    The 2026 fiscal year ends on this date. Q4 2026 results have not yet been filed in a periodic report, so the profit trend after Q3 2026 will be checked through the annual report.

  2. Around March 31, 2027

    This is around the filing deadline for the 2026 annual report. The checks are whether the operating margin holds near the 12.3% of 2025 and how the Q3 2026 gap between operating profit and net profit attributable to controlling shareholders appears on a full-year basis.

  3. Around March 2027

    This is the annual general meeting for the 2026 fiscal year. The checks are the financial statement approval and dividend resolution, and whether the holding-company and real estate leasing activities added to the articles in March 2026 appear in actual disclosures.

  4. Around May 15, 2027

    This is around the filing deadline for the Q1 2027 quarterly report. It provides a comparison with Q1 2026 operating profit of KRW 19.3 billion, and the check is whether the operating margin moves closer to the Q2 or Q3 2026 level.

12

Overall view

Miwon Specialty Chemical holds a 50% domestic market share in energy-curable resins, and its profit recovered after the 2023 trough, with 2025 operating profit of KRW 65.5 billion and an operating margin of 12.3%. Revenue held in the KRW 160 billion range in Q2 and Q3 2026.

However, Q3 2026 operating profit fell to KRW 16.7 billion and net profit attributable to controlling shareholders was only KRW 96.09 million, so the gap between operating profit and net profit is the main item to confirm. A debt ratio of 22.5% and total equity of KRW 448.5 billion reflect financial capacity.

Exports at 82.7% of sales, concentration in one material family and a 73.58% stake held by Miwon Holdings and related parties are factors to read together with the earnings volatility and the shareholding structure.

The next checks are Q4 2026 results and full-year operating margin in the 2026 annual report, followed by the Q1 2027 quarterly report.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 16 more articles and sources
  1. comp.wisereport.co.kr
  2. news.nate.com
  3. butler.works
  4. comp.wisereport.co.kr
  5. comp.fnguide.com
  6. seo.goover.ai
  7. edaily.co.kr
  8. news.bizwatch.co.kr
  9. edaily.co.kr
  10. pflow.keywordegg.com
  11. investing.com
  12. edaily.co.kr
  13. securities.miraeasset.com
  14. m.news.nate.com
  15. news.nate.com
  16. file.alphasquare.co.kr

Report written 2026-11-14 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis